Advertisement

Resonance

, Volume 23, Issue 12, pp 1359–1366 | Cite as

Nobel Prize in Physiology or Medicine – 2018

  • Arunika MukhopadhayaEmail author
General Article
  • 6 Downloads

Abstract

The Nobel Prize in Physiology or Medicine for the year 2018 was awarded to James P Allison of the United States and Tasuku Honjo of Japan for their immense contributions towards the application of immunotherapy for the treatment of cancer. To understand the ramifications of their discovery, we must first understand how the immune system works.

Keywords

Immunotherapy immune checkpoint cancer T cells lymphocytes immunity anitgen presenting cells dendritic cells 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. [1]
    L Chen and D B Flies, Molecular Mechanisms of T Cell Co-stimulation and Co-inhibition, Nat Rev Immunol., Vol.13, pp.227–242, 2013.CrossRefGoogle Scholar
  2. [2]
    T Pentcheva-Hoang, J G Egen, K Wojnoonski and J P Allison, B7-1 and B7-2 Selectively Recruit CTLA-4 and CD28 to the Immunological Synapse, Immunity., Vol.21, pp.401–413, 2004.CrossRefGoogle Scholar
  3. [3]
    E S Kim, J E Kim, M A Patel, A Mangraviti, J Ruzevick and M Lim, Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium, Journal of Immunology Research, 14, 2016.Google Scholar
  4. [4]
    O S Qureshi, Y Zheng, K Nakamura, K Attridge, C Manzotti, E M Schmidt, J Baker, L E Jeffery, S Kaur, Z Briggs, T Z Hou, C E Futter, G Anderson, L S Walker, and DM Sansom, Trans-endocytosis of CD80 and CD86: AMolecular Basis for the Cell-extrinsic Function of CTLA-4, Science, Vol.332, pp.600–603, 2011.CrossRefGoogle Scholar
  5. [5]
    D M Pardoll, The Blockade of Immune Checkpoints in Cancer Immunotherapy, Nat Rev Cancer., Vol.12, pp.252–264, 2012.CrossRefGoogle Scholar
  6. [6]
    C J Nirschl and C G Drake, Molecular Pathways: Co-expression of Immune Checkpoint Molecules: Signaling Pathways and Implications for Cancer Immunotherapy, Clin Cancer Res., Vol.19, pp.4917–4924, 2013.CrossRefGoogle Scholar
  7. [7]
    I Melero, D M Berman, M A Aznar, A J Korman, J L Perez Gracia and J Haanen, Evolving Synergistic Combinations of Targeted Immunotherapies to Combat Cancer, Nat Rev Cancer., Vol.15, pp.457–472, 2015.CrossRefGoogle Scholar
  8. [8]
    A Mullard, New Checkpoint Inhibitors Ride the Immunotherapy Tsunami, Nat Rev Drug Discov., Vol.12, pp.489–492, 2013.CrossRefGoogle Scholar

Copyright information

© Indian Academy of Sciences 2018

Authors and Affiliations

  1. 1.Department of Biological SciencesIndian Institute of Science Education and Research MohaliSAS Nagar, ManauliIndia

Personalised recommendations